• Sonuç bulunamadı

選擇性毒蕈素受體拮抗劑-Liriodenine 之化學合成研究 Synthesis of Liriodenine, a selective muscarinic antagonist

N/A
N/A
Protected

Academic year: 2021

Share "選擇性毒蕈素受體拮抗劑-Liriodenine 之化學合成研究 Synthesis of Liriodenine, a selective muscarinic antagonist"

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

選擇性毒蕈素受體拮抗劑-Liriodenine 之化學合成研究 Synthesis of Liriodenine, a selective muscarinic antagonist

中文摘要

選擇性毒蕈素受體拮抗劑-Liriodenine 之化學合成研究

Liriodenine (20)屬於 7-oxoaporphine 生物鹼,經藥理篩選發現對於 carbachol 誘發 天竺鼠支氣管及迴腸平滑肌之收縮具有鬆弛作用,但對心臟強心作用之活性僅 為平滑肌鬆弛作用之十分之一而已,表示liriodenine (20)對毒蕈素 M3 亞型受體 具有選擇性之拮抗作用。由於liriodenine (20)於化學結構與已知選擇性 M3 拮抗 物 (4-DAMP ) 不同而具構造特殊性。為提昇毒蕈素 M3 亞型受體之拮抗作用並改

善其化學性狀,經化學構造修飾並探討liriodenine 之化學構造與藥效關係是唯

一途逕。本論文係研究liriodenine 簡易且有效之化學合成方法,以期將來用於製

liriodenine 類似物,做為設計支氣管擴張劑之前導藥物重要依據。

Liriodenine 之化學製備方法乃以 piperonal 為起始物,經與 aminoacetaldehyde dimethyl acetal 縮和後,利用 Pomeranz-Fritsch 反應製成 6,7-

methylenedioxyisoquinoline(26)後,再與 benzoyl chloride 及 trimethylsilyl cyanide 製成isoquinoline Reissert compound 27。與各種鄰位碘及溴取代之苯醛類進行縮 合反應後,形成各種benzylisoquinoline 之酯類 31,32,再水解成醇類 33,34,再 氧化成酮類35,36 衍生物,最後經由分子內環化形成 liriodenine(20);環化合成 反應採用光化學、tributyltin hydride 或 Psychorr 等三種反應,其全程合成產率各 為 19 %, 17% 及 6%。其中以 tributyltin hydride 環化反應最為適宜未來擴量製備 之用。

英文摘要

Synthesis of Liriodenine, A Selective Muscarinic Antagonist

Liriodenine, an 7-oxoaporphine alkaloid was found to inhibit tracheal and ileum contraction of guinea-pig induced by carbachol. It also showed to have cardiotonic effect but only one tenth potency compared with smooth muscle relaxation effect. The pharmacological activity was demonstrated that liriodenine is a selective muscarinic M3 subtype receptor antagonist. The structure of liriodenine is completely different from the known M3 antagonist (eg. 4-DAMP). To enhance the selectivity on

muscarinic M3 antagonist activity, structural modification and SAR study is essential for liriodenine. In this thesis, we like to focus on the development of a new and facile synthesis of liriodenine. Application of the proposed synthetic method will be

beneficial to design new lead as potential bronchodilators.

Liriodenine was prepared by condensation of piperonal and aminoacetaldehyde dimethyl acetal, and then to form the 6, 7-methylenedioxyisoquinoline (27) via Pomeranz-Fritsch reaction. Then it was reacted with benzoyl chloride and

(2)

trimethylsilyl cyanide to yield isoquinoline Reissert compound 28. The Reissert 28 was condensed with o-bromo- or o-iodobenzaldehydes to form the corresponding benzylisoquinoline esters 32 and 33, and then hydrolyzed to alcohols 34 and 35 and oxidized to ketone 36 and 37. Finally, intramolecular cyclization of the alcohols 34 and 35 react either by photo irradiation or tributyltin hydride or Pschorr reaction to finish the total synthesis of liriodenine. The yields of total synthesis of liriodenine were 19% for photocyclization, 17% for organotin hydride cyclization, and 6% for Pschorr cyclization. Cyclization by tributyltin hydride is the most effective way to prepare liriodenine with high yield and it should be able to apply in large scale synthesis.

Referanslar

Benzer Belgeler

indirubin 藥理作用具有抑制 cyclin-dependent kinase(CDKs)、glycogen synthesis kinase(GSK-3)也是 aryl hydrocarbon receptor (AhR)致效劑。因 indirubin 抑制 CDK..

The ketones were reacted with malononitrile or ethyl cyanoacetate to afford 3-(dicyanomethylene)-1-phenylpyrrolidines or 3-[cyano(ethoxycarbonyl)

Based on the more potent antiproliferative activity of 7-aryl-6- azaindole-1-sulfonamides, another two novel series of 7- arylindole-1-sulfonamides and

 本研究發現尼菲迪平在螢光燈照射下會快速轉變成其亞硝基衍生物 (NIF1) ,尼卡迪平

 選擇性毒蕈素受體拮抗劑 -Liriodenine 之化學合成研究 Liriodenine (20) 屬於 7- oxoaporphine 生物鹼,經藥理篩選發現對於

體化學之研究 JKL 1067 (2,3-methylenedioxy-9,10-dimethoxyspirobenzylisoquino line) (4)是一個合成的螺旋 基異 

Denbinobin(1),為一種 phenanthrene quinone 結構的天然物,其最早被發現於 Dndrobium nobile 的成分之中。而最近有報導指出

GSTM1 null type and COMT activity may predisposes to increased oxidative damages to the women with endometriosis. According to these finding, we suggest that endometriosis leads